Cards you may also be interested in
Trends, Future Growth and Technology For Fluoroscopy Equipment Market
Growth in the fluoroscopy equipment market is attributed to factors such as the advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, the rising geriatric population, and the growing prevalence of chronic diseases.  The pandemic has also impacted the operation of manufacturing companies. Companies are functioning with a limited workforce. Moreover, the turnaround time for the delivery of products and services is affected due to newer packaging protocols and lockdown measures imposed by countries. All these factors are negatively impacting the manufacturing and supply chain of fluoroscopy products.  The evolution of fluoroscopy systems and C-arms from traditional X-ray image intensifier technology to digital flat-panel detectors (FPDs) has brought about significant advancements in fluoroscopic imaging. FPDs have a number of advantages over image intensifiers, including compact sizes and reduced radiation dose. Systems with FPDs have the potential for higher image resolution than their predecessors.  They continue to deliver the same image quality even years after use and can provide a wider and more dynamic range of imaging compared to image intensifiers. Additionally, the field of vision reduces with higher magnification in the case of image intensifiers, which does not happen if FPDs are used.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=23056341 Fluoroscopic procedures can result in high radiation dose exposure for complex procedures, such as stent placement. These procedures are time-consuming, which greatly increases the radiation that patients are exposed to and the risk of hazards such as radiation-induced injuries to the skin and underlying tissues. The long-term side-effects of prolonged radiation exposure can also include cancer.  For instance, the ACR (American College of Radiology) Appropriateness Criteria specify that for infants younger than two months, ultrasound should be considered before a fluoroscopic examination. Additionally, CT examinations can completely eliminate the need for a fluoroscopic examination, as a CT scan is noninvasive as opposed to minimally invasive fluoroscopic imaging. The growing prominence of other non-radiation imaging modalities, like ultrasound, is likely to restrain the market growth.  Many hospitals in developing countries are unable to invest in fluoroscopy equipment due to their high costs, poor reimbursement rates, and budget constraints, and therefore prefer refurbished systems. These systems are less expensive than new systems—approximately 40% to 60% of the original price.  Major players operating in the fluoroscopy equipment market include Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).
Hemodialysis and Peritoneal Dialysis Market worth $105.1 billion by 2026 - Exclusive Report by MarketsandMarkets™
According to the new market research report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Tube, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (Conventional, CAPD, Nocturnal), User (Hospital, Home Care, ASCs) - Global Forecasts to 2026", published by MarketsandMarkets™, the global Hemodialysis Dialysis Market is projected to reach USD 105.1 billion by 2026 from USD 76.9 billion in 2021, at a CAGR of 6.4% during the forecast period. Browse in-depth TOC on "Hemodialysis and Peritoneal Dialysis Market" 440 – Tables 48 – Figures 338 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279 The increasing incidence of chronic kidney disease, the availability of advanced dialysis, machines disposables and replacement fluids, and increasing government initiatives to increase the accessibility of dialysis treatment and growing adoption home hemodialysis are expected to drive market growth in the coming years The hemodialysis and peritoneal dialysis market include major Tier I and II suppliers of HD & PD products & services are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson and Company (US), Dialife SA (Switzerland), and Isopure Corp. (USThese suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. Due to the pandemic, the demand for renal replacement fluids has increased significantly worldwide. The demand for RRT among patients with COVID-19 has increased fivefold compared to the historical US populations (4.9% as of 2020 VS. 0.9% earlier) (Source: American Society of Nephrology, 2021). The gradual shift towards home hemodialysis treatment before the pandemic and the concerns over the spread of COVID-19 infection have considerably accelerated patient interest in HD treatment. This factor is likely to boost the adoption of home hemodialysis products during the epidemic. The rise in number of dialysis service provider to support the market growth during the forecast period." Significant rise in number of dialysis service provider, coupled with the growing prevalence of ESRD. Along with this growing focus of dialysis service providers towards expansion of their services offerings by launching and acquiring new dialysis centers across the globe is likely to contribute towards the growth of the segment. Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279 Asia Pacific likely to emerge as the fastest-growing hemodialysis and peritoneal dialysis market, globally Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 8.8% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, increase patient population with acute kidney disease, diabetes, hypertension are factors likely to support the growth of hemodialysis and peritoneal dialysis market in the region. Moreover, initiative by government to increase the accessibility of the dialysis treatment in the region are likely to offer huge opportunity for the players to capture large customer base. Prominent players in this Hemodialysis Market are Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), among others Browse Related Reports: China Hemodialysis and Peritoneal Dialysis Market by Product & Services (HD, PD, Machine, Dialyzer, Concentrate, Dialysate, Catheter, Service), Modality (CAPD, APD, Nocturnal), End User (Hospital, Independent Center, Home Dialysis) - Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/china-hemodialysis-peritoneal-dialysis-market-150472097.html Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare) - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html
High Growth of Digital 3D Printing is Driven By its Affordability and Accuracy
The dental 3D printing medical devices market is primarily driven by factors such as the high incidence of dental caries and other dental diseases, rising demand for cosmetic dentistry, the growing adoption of dental 3D printers in hospitals and clinics, and rapid growth in the geriatric population. In the optimistic scenario, it could be assumed that the COVID-19 pandemic would create a long-term positive impact on the overall dental 3D printing market. The dental 3D printing market was initially negatively impacted by the COVID-19 pandemic, as most dental offices, clinics, and laboratories were closed in many parts of the world due to lockdowns and quarantine restrictions in early 2020.  In an optimistic scenario, the need for smoother clinical workflows, faster turnaround times, and fewer dental appointments could boost the market growth. Dentists may be more likely to invest in technologies like CAD/CAM and dental 3D printing to reduce the time taken to deliver dental appliances and treatment, and patients may be more likely to opt for these solutions for the same reason.  According to the American College of Prosthodontists, more than 36 million Americans are completely edentulous, and around 120 million Americans are missing at least one tooth. As dental implants, dental prosthetics, and other dental products manufactured by dental 3D printers find high use in the restoration of the dental structure, the high incidence of target diseases will play a key role in the growth of the dental 3D printing market during the forecast period.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258228239 The dental 3D printing market is segmented into vat photopolymerization, fused deposition modeling, selective laser sintering, PolyJet printing, and other technologies. The vat photopolymerization segment accounts for the largest share of the dental 3D printing market. Its large share can be attributed to its wide applications in implantology, prosthodontics, maxillofacial surgery, porous scaffolds, and dental restorations.  The implantology segment is expected to grow at the highest CAGR in the market during the forecast period. The growth of this segment can be attributed to the growing preference for manufacturing dental implants using dental 3D printing, the advantages offered by 3D-printed dental implants, advances in materials used for 3D printing implants, and the increasing application of 3D printing in dental implantology.  The dental laboratories segment is expected hold the largest share in the market during the forecast period. The large share of this segment can be attributed to the increasing number of dental laboratories, expansion of dental laboratories in developing countries, rapid adoption of advanced technologies by small and large laboratories across the globe, and the outsourcing of manufacturing functions to dental laboratories. Prominent players in the Dental 3D printing market include 3D Systems (US), Stratasys Ltd. (US/Israel), Renishaw plc (UK), Roland DG (Japan), SLM Solutions Group AG (Germany), EnvisionTEC (Germany), DENTSPLY Sirona (US), Formlabs (US), and Prodways Group (France).
Industry Trends, Growth and Analysis For Healthcare Fraud Analytics
Fraud analytics is the efficient use of data analytics and related business insights developed through statistical, quantitative, predictive, comparative, cognitive, and other emerging applied analytical models for detecting and preventing healthcare fraud. The global healthcare fraud analytics market is projected to reach USD 5.0 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 26.7% during the forecast period. Market growth can be attributed to a large number of fraudulent activities in healthcare, the increasing number of patients seeking health insurance, high returns on investment, and the rising number of pharmacy claims-related frauds. However, the dearth of skilled personnel is expected to restrain the growth of this market.  The global healthcare fraud analytics market is facing a plethora of challenges. Travel bans and quarantines, halt of indoor/outdoor activities, temporary shutdown of business operations, supply-demand fluctuations, stock market volatility, falling business assurance, and many uncertainties are somehow exerting a partial negative impact on the business dynamics.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221837663 The healthcare industry has been witnessing a number of cases of fraud, done by patients, doctors, physicians, and other medical specialists. Many healthcare providers and specialists have been observed to be engaged in fraudulent activities, for the sake of profit. In the healthcare sector, fraudulent activities done by patients include the fraudulent procurement of sickness certificates, prescription fraud, and evasion of medical charges.  A couple of reasons contributing to the growth of the health insurance market include the rise in the aging population, growth in healthcare expenditure, and increased burden of diseases. In the US, the number of citizens without health insurance has significantly decreased, from 48 million in 2010 to 28.6 million in 2016. In 2017, 12.2 million people signed up for or renewed their health insurance during the 2017 open enrollment period (Source: National Center for Health Statistics).  This growth is aided by the increasing affordability of health insurance for the middle class in this region and the rising awareness regarding the benefits of health insurance. In the UAE, as per a new regulatory policy (2017), any citizen residing and working in the UAE needs to be insured medically.   Major players in this market include IBM Corporation (US), Optum, Inc. (US), Cotiviti, Inc. (US), Change Healthcare (US), Fair Isaac Corporation (US), SAS Institute Inc. (US), EXLService Holdings, Inc. (US), Wipro Limited (India), Conduent, Incorporated (US), CGI Inc. (Canada), HCL Technologies Limited (India), Qlarant, Inc. (US), DXC Technology (US), Northrop Grumman Corporation (US), LexisNexis (US), Healthcare Fraud Shield (US), Sharecare, Inc. (US), FraudLens, Inc. (US), HMS Holding Corp. (US), Codoxo (US), H20.ai (US), Pondera Solutions, Inc. (US), FRISS (The Netherlands), Multiplan (US), FraudScope (US), and OSP Labs (US).  Research Developments Analysis 1. In January 2019, LexisNexis Risk Solutions collaborated with QuadraMed to enable patient identification capabilities and reduce the number of duplicate identities & fraudulent claims. 2. In August 2018, Verscend Technologies acquired Cotiviti Holdings. This acquisition helped improve the affordability of fraud detection solutions. 3. In June 2018, SAS Institute & Prime Therapeutics LLC teamed up, enabling Prime Therapeutics to utilize SAS’s analytic capabilities to combat the opioid crisis in the US
Refurbished Medical Equipment Market is Set to $21.2 billion by 2025
The growth of the global refurbished medical equipment market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devices, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.  However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth. Furthermore, the growth of the market is expected to be slowed temporarily due to the COVID-19 pandemic during the forecast period.  The refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770 The rising demand for diagnostic imaging procedures, the high price of new medical imaging equipment, a growing number of target diseases, widening application of diagnostic imaging procedures, regulatory approvals in using refurbished medical equipment, low purchasing power in emerging economies, and established & government validated refurbishment processes adopted by major OEMs are factors expected to drive the growth of this market segment in the coming years.  The hospitals' segment accounted for the largest share of the market in 2019. The rising adoption of refurbished medical equipment, increasing focus of hospitals on providing affordable treatment and care, and growing emphasis on high returns on investment are some of the key factors driving the growth of this market.  The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the large patient pool in the region, increasing privatization in the healthcare sector, huge patient population base, and high demand for refurbished medical equipment by low-budget hospitals and clinics.  Research Developments 1. In 2020, Siemens Healthineers (Germany) and Hamilton Health Sciences (Canada) have signed a 15 years contract that can be extended by another 10 years to provide comprehensive services for the latest imaging equipment at Hamilton Health Sciences hospitals in Canada. The deal size was approximately USD 192 million. 2. In 2019, US Med-Equip (US) acquired Medical Support Products (US) to increase the capability, national expansion, and provide greater product and service solutions across the US. 3. In 2019, Avante Health Solutions opened a new Charlotte facility in North Carolina, US. This will house three business divisions of the company viz., Avante Diagnostic Imaging, Avante Oncology, and Avante Ultrasound. 4. In 2018, Koninklijke Philips (Netherlands) acquired AGITO Medical (Denmark), strengthening its refurbished medical equipment portfolio of products, parts, and services. 5. In 2017, US Med-Equip  (US), and the Owner-Research group (US) signed a partnership to augment the economy and medical equipment products and services across hospitals in the US.
Dairy Herd Management Market Facts, And Analytical Insights
The increasing herd size of dairy farms and growing consumption of milk and dairy products are the primary growth drivers for the dairy herd management market. Increasing public-private funding and investments in dairy farming and technological advancements are further aiding the market growth.  On the other hand, ongoing campaigns to save dairy animals from unethical herd management practices are expected to restrain the growth of this market during the forecast period. Along with this, the shortage of trained dairy professionals is further expected to challenge the growth of this market. The dairy herd management market is segmented based on product, application, farm size and region.  Due to the pandemic, the demand for ‘out of home’ dairy products has reduced significantly, misbalanced supply and demand, and negatively impacted global farmgate milk prices. Additionally, the profitability of dairy farms is reduced due to the increased feed costs, which are likely to last till the first half of 2021. Still, a recovery is expected during the second half of this year. Due to the pandemic and the movement restrictions associated with it, the labor-intensive dairy industry has faced a production shortage as the majority of tasks in animal farms are performed by skilled laborers. This has hampered the supply of laborers in farms and processing plants and milk transportation.  According to the OECD-FAO Agricultural Outlook 2019-2028, compared to the previous decade, the estimated growth of cowherds is 1.2% per annum and is higher than the estimated average yield growth (0.4%) as cowherds are projected to grow faster in countries with low yields.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36572220 Dairy herd management products are used in almost all functional aspects of modern dairy farms, such as animal comfort, calf management, feeding management, heat stress management, milk harvesting, and reproduction management. The smooth flow of these procedures requires great precision and skilled, trained professionals who can understand and operate dairy herd management systems efficiently.  The dairy herd management market is categorized into milk harvesting, feeding, breeding, cow comfort, and heat stress management, calf management, health management, and other applications (such as genetic management, cattle sorting, and weighing). The milk harvesting segment held the largest share in 2020. The large share is attributed to the increasing preference for automated milk harvesting systems, the high focus of farmers on increasing milk yield, and the growing demand for dairy products.  The global dairy herd management market is consolidated. The prominent players operating in this market include DeLaval Inc. (Sweden), Merck & Co., Inc. (US), GEA Group Aktiengesellschaft (Germany), BouMatic (US), and Afimilk Ltd. (Israel).
Growing Support and Collaboration for Developing OTC Tests
 The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.  Growth in this market can be attributed to factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China.   The lateral flow assays segment is projected to grow at the highest rate in the market, by technology. In the past few years, the lateral flow assay POC testing market has grown significantly due to the increasing adoption of LFA testing products in-home care.   Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178 The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. The high growth in this regional segment is majorly attributed to the increasing patient population base and the growing prevalence of infectious diseases.  Key market players The key players operating in the global Over The Counter/OTC test industry are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the OTC tests market.  Research Developments: 1. In 2019, SD Biosensor launched STANDARD GlucoNavii GDH for blood glucose monitoring. 2. In 2019, LabStyle Innovations entered into an agreement with Better Living Now (BLN) for the distribution of its Blood Glucose Monitoring System and the DarioEngage digital health platform. 3. In 2018, DarioHealth partners with Byram Healthcare to further expand insurance health coverage for consumers in the US. 4. In 2016, Sinocare acquired PTS Diagnostics, to strengthen its product portfolio and accelerate future growth in the diagnostic testing market. 
Order Xanax online for Anxiety and panic attacks
order now with 20% discount >>>https://onlinehealths.com/product-category/buy-xanax-online/(hurry up) Order Xanax online medicine uses to treat Anxiety and panic attacks related disorders. But before consumption of this medicine, first of all you will have to know about all the information about how many doses are right for use and how the type of this medicine can be effective, otherwise, you will put yourself in trouble because of incorrect use. Does teladoc prescribe Xanax? Teladoc therapists do not prescribe medications. What is the most Xanax a doctor can prescribe? When you suffer from these Anxiety and panic disorders problems. So, your doctor can be prescribes for the consumption of this medicine. In starting you can take Xanax 0.25 mg, Xanax 0.5 mg tablet medicine and after some time may your doctor will increase slowly some dose. But does not usually exceed more than 4 mg of medicine. Can you get Xanax from urgent care? Can you get Xanax over the counter in the USA? If you want to purchase Xanax medicine. Then a good opportunity is available in front of you. The medicine is easily available over the counter. And in your general stores. But if you would not like to go outside from your home and also, you want to get your medicine at your home. Then you can order Xanax online medicine. Because there are more trustworthy websites available for you. They provide you with all the medicines overnight delivery at your home. Can doctors on demand prescribe anxiety meds? Yes, Xanax 0.5 mg tablet medicine’s more in demand by doctors. Because Xanax medicine treats anxiety and panic disorder rapid relief, and most doctors suggest their patients for their consumption of this medicine. Will doctors prescribe Xanax long-term? In rare cases, doctors prescribe you this medicine for a long time. If your doctor prescribes for a long time. So, according to your doctor, you should follow your dose and diet and all must take all the precautions. Why is Xanax being taken off the market? What works better than Xanax? Xanax medicine is available in the general store. But not easily available in the market then you can buy Xanax online from the USA’s worthy websites. Klonopin medicines are more effective than Xanax medicine. Does Klonopin feel like Xanax? Klonopin medicine is more addictive than Xanax medicine. Klonopin medicine produces more feelings of euphoria. What is the generic version of Xanax? The generic name of Xanax medicine is Alprazolam. It is uses to treat anxiety and panic disorders related problems. If you seem like you are having this problem. So, you should immediately consult your doctor for the treatment on time. Conclusion I hope you will understand about Xanax medicine. Also, if you are bearing anxiety and panic attacks. So, in this condition, the consumption of Xanax medicine can be very effective. Also, you should order Xanax online from the USA’s trustworthy websites. And the website provides you with Xanax online at overnight delivery at your home. But, I will remind you of that. Before taking this medicine you should take consultation from your doctor for the right treatment by which you can get fast relief in your problem.